In March 2026, Tiger Woods was arrested in Florida after a crash involving his SUV, which clipped a trailer and rolled over. The incident occurred on March 27, and Woods was charged with driving under the influence. Following the crash, he passed a breathalyzer test but declined to submit to a urine test for other substances. This raised concerns among law enforcement officials, who noted signs of impairment and discovered prescription pain medications in his possession during the arrest. Woods maintained that he had not consumed alcohol or illegal drugs. After the incident, Woods announced he would be stepping away from golf to focus on his health and treatment priorities. Woods has a documented history of pain management and has undergone multiple surgeries due to injuries during his career. The DUI incident marks his second arrest for such charges; the first incident happened in 2009, where he was not charged despite having sleeping pills in his system. Legal experts noted that Woods' refusal to take a urine test might complicate his defense despite the prosecution's burden to prove impairment. As part of the ongoing legal proceedings, prosecutors are seeking copies of Woods' prescription medication records from a pharmacy in Palm Beach, Florida. This request, aimed at gathering evidence, highlights the potential for legal ramifications regarding his prescribed medications, including dosage instructions and warnings about operating vehicles. The court filing will officially seek these records in late April. The case remains at an early stage, and no trial date has been scheduled yet, creating an uncertain timeline for both Woods’ legal challenges and his return to competitive golf. Given his past experiences, this incident brings to the forefront questions regarding public safety, the responsibilities of high-profile athletes with health issues, and the impact of prescription medications on performance and judgment.